Casdin Capital, LLC 13D/13G Filings for Tango Therapeutics, Inc. (TNGX)

Casdin Capital, LLC 13D and 13G filings for Tango Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2023-02-13
9:34 pm
Sale		 2022-12-31 13G Tango Therapeutics, Inc.
TNGX		 Casdin Capital, LLC 0
0.000%		 -5,487,910decrease
(Position Closed)		 Filing
2021-08-19
4:59 pm
Purchase		 2021-08-10 13G Tango Therapeutics, Inc.
TNGX		 Casdin Capital, LLC 5,487,910
6.300%		 5,487,910increase
(New Position)		 Filing